Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2018

18.04.2018 | Breast Oncology

Profiling Surgeon Performance for Breast Cancer Lumpectomy by Composite Measurement of Reoperations, Cosmetic Outcomes, and Patient Preferences

verfasst von: Annie L. Dunham, MD, Luis D. Ramirez, MPH, Choua A. Vang, BS, Jared H. Linebarger, MD, Jeffrey Landercasper, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients want information to search for destination of care for breast-conserving surgery (BCS). To inform patients wanting a lumpectomy, we aimed to develop a pilot project that communicated composite quality measure (QM) results using a ‘4-star’ rating system. Two patient-centered QMs were included in the model—reoperation rate (ROR) and cosmetic outcome (COSM).

Methods

A prospective database was reviewed for stage 0–3 patients undergoing initial lumpectomy by three surgeons from 2010 to 2015. Self-reported COSM was assessed by survey. Multivariate analyses were used to test for interactions between surgeon and other variables known to influence RORs and COSMs. Models of surgeon profiling were developed that summed the ROR and COSM performance scores, then reported results using a Centers for Medicare and Medicaid Services (CMS) star-type system. Functionality for a patient to ‘weight’ the importance of the ratio of ROR:COSM before profiling was introduced.

Results

The unadjusted ROR for stage 1–3 patients for three surgeons was 9.5, 13.0, and 16.3%, respectively (p = 0.179) [overall rate 10.4% (38/366)]. After risk adjustment, differences between surgeons were observed for RORs, but not COSMs. Overall, patients reported excellent, good, fair, and poor COSMs of 55, 30, 11 and 4%, respectively. Composite star scores reflected differences in performance by surgeon, which could increase, or even disappear, dependent on the patient’s weighting of the ROR:COSM ratio.

Conclusion

Composite measures of performance can be developed that allow patients to input their weighted preferences and values into surgeon profiling before they consider a destination of care for BCS.
Literatur
1.
Zurück zum Zitat Jha AK. Public reporting of surgical outcomes: surgeons, hospitals, or both? JAMA 2017;318:1429–1430.CrossRefPubMed Jha AK. Public reporting of surgical outcomes: surgeons, hospitals, or both? JAMA 2017;318:1429–1430.CrossRefPubMed
4.
Zurück zum Zitat Ong WL, Schouwenburg MG, van Bommetl ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative. JAMA Oncol 2017; 3:677–685.CrossRefPubMed Ong WL, Schouwenburg MG, van Bommetl ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative. JAMA Oncol 2017; 3:677–685.CrossRefPubMed
5.
Zurück zum Zitat Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol 2016; 23:2385–2390.CrossRefPubMed Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol 2016; 23:2385–2390.CrossRefPubMed
6.
Zurück zum Zitat Spatz ES, Krumholz HM, Moulton BW. Prime time for shared decision making. JAMA 2017; 317:1309–1310.CrossRefPubMed Spatz ES, Krumholz HM, Moulton BW. Prime time for shared decision making. JAMA 2017; 317:1309–1310.CrossRefPubMed
7.
Zurück zum Zitat Dzau VJ, McClellan MB, McGinnis JM, et al. Vital directions for health and health care: priorities from a National Academy of Medicine Initiative. JAMA 2017; 317:1461–1470.CrossRefPubMed Dzau VJ, McClellan MB, McGinnis JM, et al. Vital directions for health and health care: priorities from a National Academy of Medicine Initiative. JAMA 2017; 317:1461–1470.CrossRefPubMed
8.
Zurück zum Zitat Barry MJ, Edgman-Levitan S. Shared decision making: pinnacle of patient-centered care. N Engl J Med 2012; 366:780–781.CrossRefPubMed Barry MJ, Edgman-Levitan S. Shared decision making: pinnacle of patient-centered care. N Engl J Med 2012; 366:780–781.CrossRefPubMed
9.
Zurück zum Zitat Mullangi S, Schleicher S, Feeley TW. Outcome measurement in value-based payments. JAMA Oncology 2017; 3:1019–1020.CrossRefPubMed Mullangi S, Schleicher S, Feeley TW. Outcome measurement in value-based payments. JAMA Oncology 2017; 3:1019–1020.CrossRefPubMed
11.
Zurück zum Zitat Rajaram R, Chung JW, Cohen ME, et al. Association of the 2011 ACGME resident duty hour reform with postoperative patient outcomes in surgical specialties. J Am Coll Surg 2015; 221:748–757.CrossRefPubMed Rajaram R, Chung JW, Cohen ME, et al. Association of the 2011 ACGME resident duty hour reform with postoperative patient outcomes in surgical specialties. J Am Coll Surg 2015; 221:748–757.CrossRefPubMed
12.
Zurück zum Zitat Dimick J, Birkmeyer NJ, Finks JF, Share DA, English WJ, Carlin AM, Birkmeyer JD. Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg 2014; 149:10–16.CrossRefPubMedPubMedCentral Dimick J, Birkmeyer NJ, Finks JF, Share DA, English WJ, Carlin AM, Birkmeyer JD. Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg 2014; 149:10–16.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Dimick JB, Staiger DO, Hall BL, Ko CY, Birkmeyer JD. Composite measures for profiling hospitals on surgical morbidity. Ann Surg 2013; 257:67–72.CrossRefPubMed Dimick JB, Staiger DO, Hall BL, Ko CY, Birkmeyer JD. Composite measures for profiling hospitals on surgical morbidity. Ann Surg 2013; 257:67–72.CrossRefPubMed
17.
Zurück zum Zitat McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA 2012; 307:467–475.CrossRefPubMed McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA 2012; 307:467–475.CrossRefPubMed
18.
Zurück zum Zitat Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Database, 2004–2010. JAMA Surg 2014;149:1296–1305.CrossRefPubMed Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Database, 2004–2010. JAMA Surg 2014;149:1296–1305.CrossRefPubMed
19.
Zurück zum Zitat Decker MR, Trentham-Dietz A, Loconte NK, et al. The role of intraoperative pathologic assessment in the surgical management of ductal carcinoma in situ. Ann Surg Oncol 2016; 23:2788–2794.CrossRefPubMedPubMedCentral Decker MR, Trentham-Dietz A, Loconte NK, et al. The role of intraoperative pathologic assessment in the surgical management of ductal carcinoma in situ. Ann Surg Oncol 2016; 23:2788–2794.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) database. Ann Surg Oncol 2014; 21:3185–3191.CrossRefPubMed Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) database. Ann Surg Oncol 2014; 21:3185–3191.CrossRefPubMed
21.
Zurück zum Zitat Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ 2012; 345:e4505.CrossRefPubMedPubMedCentral Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ 2012; 345:e4505.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Schulman AM, Mirrielees JA, Leverson G, Landercasper J, Greenberg C, Wilke LG. Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM database following the SSO-ASTRO “No Ink on Tumor” guidelines. Ann Surg Oncol 2017;24:52–58.CrossRefPubMed Schulman AM, Mirrielees JA, Leverson G, Landercasper J, Greenberg C, Wilke LG. Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM database following the SSO-ASTRO “No Ink on Tumor” guidelines. Ann Surg Oncol 2017;24:52–58.CrossRefPubMed
23.
Zurück zum Zitat Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg 2016; 151:648–655.CrossRefPubMed Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg 2016; 151:648–655.CrossRefPubMed
25.
Zurück zum Zitat Cody HS 3rd, Van Zee KJ. Reexcision—the other breast cancer epidemic. N Engl J Med 2015; 373: 568–569.CrossRefPubMed Cody HS 3rd, Van Zee KJ. Reexcision—the other breast cancer epidemic. N Engl J Med 2015; 373: 568–569.CrossRefPubMed
26.
27.
Zurück zum Zitat St John ER, Al-Khudairi R, Ashrafian H, et al. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery: a meta-analysis. Ann Surg 2017; 265:300–310.CrossRefPubMed St John ER, Al-Khudairi R, Ashrafian H, et al. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery: a meta-analysis. Ann Surg 2017; 265:300–310.CrossRefPubMed
28.
Zurück zum Zitat Boughey JC, Keeney GL, Radensky P, Song CP, Habermann EB. Economic implications of widespread expansion of frozen section margin analysis to guide surgical resection in women with breast cancer undergoing breast-conserving surgery. J Oncol Pract 2016; 12:e413–e422.CrossRefPubMed Boughey JC, Keeney GL, Radensky P, Song CP, Habermann EB. Economic implications of widespread expansion of frozen section margin analysis to guide surgical resection in women with breast cancer undergoing breast-conserving surgery. J Oncol Pract 2016; 12:e413–e422.CrossRefPubMed
29.
Zurück zum Zitat Abe SE, Hill JS, Han Y, et al. Margin re-excision and local recurrence in invasive breast cancer: a cost analysis using a decision tree model. J Surg Oncol 2015;112:443–448.CrossRefPubMed Abe SE, Hill JS, Han Y, et al. Margin re-excision and local recurrence in invasive breast cancer: a cost analysis using a decision tree model. J Surg Oncol 2015;112:443–448.CrossRefPubMed
30.
Zurück zum Zitat Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol 2017;3:1352–1357.CrossRefPubMedPubMedCentral Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol 2017;3:1352–1357.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Bilimoria KY, Barnard C. The new CMS hospital quality star ratings: the stars are not aligned. JAMA 2016; 316:1761–1762.CrossRefPubMed Bilimoria KY, Barnard C. The new CMS hospital quality star ratings: the stars are not aligned. JAMA 2016; 316:1761–1762.CrossRefPubMed
32.
Zurück zum Zitat Schwartz T, Degnim AC, Landercasper J. Should re-excision lumpectomy rates be a quality measure in breast-conserving surgery? Ann Surg Oncol 2013; 20:3180–3183.CrossRefPubMed Schwartz T, Degnim AC, Landercasper J. Should re-excision lumpectomy rates be a quality measure in breast-conserving surgery? Ann Surg Oncol 2013; 20:3180–3183.CrossRefPubMed
33.
Zurück zum Zitat Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol 2015; 22:3174–3183.CrossRefPubMedPubMedCentral Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol 2015; 22:3174–3183.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Morrow M, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA 2012; 307:509–510.CrossRefPubMed Morrow M, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA 2012; 307:509–510.CrossRefPubMed
35.
Zurück zum Zitat Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979; 5:257–261.CrossRefPubMed Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979; 5:257–261.CrossRefPubMed
36.
Zurück zum Zitat Beadle GF, Silver B, Botnick L, Hellman S, Harris JR. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 1984; 54:2911–2918.CrossRefPubMed Beadle GF, Silver B, Botnick L, Hellman S, Harris JR. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 1984; 54:2911–2918.CrossRefPubMed
37.
Zurück zum Zitat Cardoso MJ, Cardoso JS, Vrieling C, et al. Recommendations for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat 2012; 135:629–637.CrossRefPubMed Cardoso MJ, Cardoso JS, Vrieling C, et al. Recommendations for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat 2012; 135:629–637.CrossRefPubMed
38.
Zurück zum Zitat De La Cruz L, Blankenship SA, Chatterjee A, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol 2016; 23:3247–3258.CrossRef De La Cruz L, Blankenship SA, Chatterjee A, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol 2016; 23:3247–3258.CrossRef
39.
Zurück zum Zitat Smith TJ, Landercasper J, Gundrum JD, De Maiffe BM, Andersen JJ, Johnson JM, et al. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach. J Surg Oncol 2010;102:34–38.CrossRefPubMed Smith TJ, Landercasper J, Gundrum JD, De Maiffe BM, Andersen JJ, Johnson JM, et al. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach. J Surg Oncol 2010;102:34–38.CrossRefPubMed
40.
Zurück zum Zitat Landercasper J, Bennie B, Parsons BM, Dietrich LL, Greenberg CC, Wilke LG, Linebarger JH. Fewer reoperations after lumpectomy for breast cancer with neoadjuvant rather than adjuvant chemotherapy: a report from the national cancer database. Ann Surg Oncol 2017; 24:1507–1515.CrossRefPubMedPubMedCentral Landercasper J, Bennie B, Parsons BM, Dietrich LL, Greenberg CC, Wilke LG, Linebarger JH. Fewer reoperations after lumpectomy for breast cancer with neoadjuvant rather than adjuvant chemotherapy: a report from the national cancer database. Ann Surg Oncol 2017; 24:1507–1515.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer 2010; 46:2344–2356.CrossRefPubMed Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer 2010; 46:2344–2356.CrossRefPubMed
42.
Zurück zum Zitat Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001. Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001.
44.
Zurück zum Zitat Linebarger J, Landercasper J, Ellis RL, et al. Core needle biopsy rate for new cancer diagnosis in an interdisciplinary breast center: evaluation of quality of care 2007–2008. Ann Surg 2012; 255:38–43.CrossRefPubMed Linebarger J, Landercasper J, Ellis RL, et al. Core needle biopsy rate for new cancer diagnosis in an interdisciplinary breast center: evaluation of quality of care 2007–2008. Ann Surg 2012; 255:38–43.CrossRefPubMed
45.
Zurück zum Zitat Adegboyega TO, Landercasper J, Linebarger JH, et al. Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Cancer Netw 2015; 13:177–183.CrossRef Adegboyega TO, Landercasper J, Linebarger JH, et al. Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Cancer Netw 2015; 13:177–183.CrossRef
46.
Zurück zum Zitat Landercasper J, Ellis RL, Mathiason MA, et al. A community breast center report card determined by participation in a national breast cancer quality initiative. Breast J 2010; 16:472–480.CrossRefPubMed Landercasper J, Ellis RL, Mathiason MA, et al. A community breast center report card determined by participation in a national breast cancer quality initiative. Breast J 2010; 16:472–480.CrossRefPubMed
47.
Zurück zum Zitat Mook J, Klein R, Kobbermann A, et al. Volume of excision and cosmesis with routine cavity shave margins technique. Ann Surg Oncol 2012; 19:886–891.CrossRefPubMed Mook J, Klein R, Kobbermann A, et al. Volume of excision and cosmesis with routine cavity shave margins technique. Ann Surg Oncol 2012; 19:886–891.CrossRefPubMed
48.
Zurück zum Zitat Volders JH, Haloua MH, Krekel NM, et al. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: final outcomes of a randomized controlled trial (COBALT). Eur J Surg Oncol 2017;43:649–657.CrossRefPubMed Volders JH, Haloua MH, Krekel NM, et al. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: final outcomes of a randomized controlled trial (COBALT). Eur J Surg Oncol 2017;43:649–657.CrossRefPubMed
49.
Zurück zum Zitat Ojala K, Meretoja TJ, Leidenius MH. Aesthetic and functional outcome after breast conserving surgery—comparison between conventional and oncoplastic resection. Eur J Surg Oncol 2017; 43:658–664.CrossRefPubMed Ojala K, Meretoja TJ, Leidenius MH. Aesthetic and functional outcome after breast conserving surgery—comparison between conventional and oncoplastic resection. Eur J Surg Oncol 2017; 43:658–664.CrossRefPubMed
50.
Zurück zum Zitat Eck DL, Koonce SL, Goldberg RF, Bagaria S, Gibson T, Bowers SP, McLaughlin SA. Breast surgery outcomes as quality measures according to the NSQIP database. Ann Surg Oncol 2012; 19:3212–3217.CrossRefPubMed Eck DL, Koonce SL, Goldberg RF, Bagaria S, Gibson T, Bowers SP, McLaughlin SA. Breast surgery outcomes as quality measures according to the NSQIP database. Ann Surg Oncol 2012; 19:3212–3217.CrossRefPubMed
51.
Zurück zum Zitat El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: National Benchmarks for Standards of Care. Ann Surg 2007; 245:665–671.CrossRefPubMedPubMedCentral El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: National Benchmarks for Standards of Care. Ann Surg 2007; 245:665–671.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Carter SA, Lyons GR, Kuerer HM, et al. Operative and oncologic outcomes in 9861 patients with operable breast cancer: single-institution analysis of breast conservation with oncoplastic reconstruction. Ann Surg Oncol 2016; 23:3190–3198.CrossRefPubMed Carter SA, Lyons GR, Kuerer HM, et al. Operative and oncologic outcomes in 9861 patients with operable breast cancer: single-institution analysis of breast conservation with oncoplastic reconstruction. Ann Surg Oncol 2016; 23:3190–3198.CrossRefPubMed
53.
Zurück zum Zitat Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol 2015; 22:361–369.CrossRefPubMed Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol 2015; 22:361–369.CrossRefPubMed
57.
Zurück zum Zitat Landercasper J, Bailey L, Buras R, et al. The American Society of Breast Surgeons and Quality Payment Programs: ranking, defining, and benchmarking more than 1 million patient quality measure encounters. Ann Surg Oncol. 2017;24(10):3093–3106.CrossRefPubMedPubMedCentral Landercasper J, Bailey L, Buras R, et al. The American Society of Breast Surgeons and Quality Payment Programs: ranking, defining, and benchmarking more than 1 million patient quality measure encounters. Ann Surg Oncol. 2017;24(10):3093–3106.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Porter M, Kaplan RS. How to pay for health care. Harv Bus Rev 2016; 94:88–100.PubMed Porter M, Kaplan RS. How to pay for health care. Harv Bus Rev 2016; 94:88–100.PubMed
59.
Zurück zum Zitat Porter ME, Teisberg EO. How physicians can change the future of health care. JAMA 2007; 297:1103–1111.CrossRefPubMed Porter ME, Teisberg EO. How physicians can change the future of health care. JAMA 2007; 297:1103–1111.CrossRefPubMed
Metadaten
Titel
Profiling Surgeon Performance for Breast Cancer Lumpectomy by Composite Measurement of Reoperations, Cosmetic Outcomes, and Patient Preferences
verfasst von
Annie L. Dunham, MD
Luis D. Ramirez, MPH
Choua A. Vang, BS
Jared H. Linebarger, MD
Jeffrey Landercasper, MD
Publikationsdatum
18.04.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6479-5

Weitere Artikel der Ausgabe 7/2018

Annals of Surgical Oncology 7/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.